(Q79411247)
Statements
Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia (English)
Jeffrey Lieberman
Jody Sindelar
Edward A Miller
Haiqun Lin
Joseph McEvoy
Sonia M Davis
Richard S E Keefe
Marvin Swartz
Diana O Perkins
John K Hsiao
CATIE Study Investigators
1 December 2006